Cue Biopharma
47 hedge funds and large institutions have $11.9M invested in Cue Biopharma in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SG
51
StoneX Group
New York
| – | -$12.8K | -14,058 | Closed |
|
52
Group One Trading
Chicago,
Illinois
| – | -$12.4K | -13,572 | Closed |
|
|
TSS
53
Two Sigma Securities
New York
| – | -$9.47K | -10,390 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | -$3.53K | -3,874 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$2K | -2,395 | Closed |
|
|
MG
56
Mather Group
Chicago,
Illinois
| – | -$911 | -1,000 | Closed |
|
|
SFG
57
Stonebridge Financial Group
Wormleysburg,
Pennsylvania
| – | -$56 | -62 | Closed |
|